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ScienceDirectToll-like receptors (TLRs) are important transmembrane
proteins of the innate immune system that detect invading
pathogens and subsequently orchestrate an immune response.
The ensuing inflammatory processes are connected to lipid
metabolism at multiple levels. Here, we describe different
aspects of how membrane lipids can shape the response of
TLRs. Recent reports have uncovered the role of individual lipid
species on membrane protein function and mouse models
have contributed to the understanding of how changes in lipid
metabolism alter TLR signaling, endocytosis, and cytokine
secretion. Finally, we discuss the importance of systematic
approaches to identify the function of individual lipid species or
the composition of membrane lipids in TLR-related processes.
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Introduction
Toll-like receptors (TLRs) are a family of proteins that
recognize conserved pathogen-associated molecular pat-
terns and serve as sentinels of the innate immune system.
TLRs encounter these patterns at different subcellular
locations and can be categorized accordingly: bacterial
components such as lipopeptides or flagellin are recog-
nized at the plasma membrane by TLR2-containing or
TLR5-containing receptor complexes, whereas endoso-
mal TLRs, such as TLR3, 7, 8, and 9 typically recognize
pathogen-derived nucleic acids. TLR4, the receptor for
bacterial lipopolysaccharide (LPS), has been reported toCurrent Opinion in Cell Biology 2016, 39:28–36 signal from both plasma and endosomal membranes. Upon
recognition, receptor signaling leads to the induction of
inflammatory genes, including cytokines and chemokines,
via the activation of specific transcription factors [1,2].
Like all transmembrane proteins, TLRs are embedded in
cellular membranes composed of proteins and lipids that
organize and regulate receptor-signaling processes
(Figure 1) [1,3]. Similarly to the advent of proteomics
for a systems-level understanding of protein function in
cellular systems, mass spectrometry (MS)-based lipido-
mics provides a toolkit to study the complexity of lipids
by identifying thousands of different cellular lipid species
[4,5]. These species vary in structural features such as their
backbone, fatty acid chain length, saturation level, and
head group, thereby generating a highly diverse repertoire
of molecules [3]. Generally, these membrane lipids are
divided into the main groups of glycerophospholipids,
sphingolipids, and sterols. In this review, we present the
current knowledge on the crosstalk between TLR biology
and membrane lipid composition and we further discuss
the importance of understanding the functional role of
individual lipid species in TLR-related processes.
Lipid metabolism and inflammatory responses
The impact of altered serum lipid composition on inflam-
matory events is well described. For instance, elevated
lipid levels are linked to decreased TLR responses as has
been observed in a mouse model of dyslipidemia [6]. Here,
the authors could show that mice with increased plasma
levels of cholesterol and triglycerides were also more
susceptible to Leishmania major infection and secreted
smaller amounts of the TLR-induced cytokines IL-
12p40, TNF, and IL-6. Other studies also connected
dyslipidemic conditions to increased bacterial or viral
infections [7,8]. Indeed, altering the lipid metabolism is
one acute response of the host upon infection [9]. This
metabolic rearrangement ensures an adequate supply of
immune cells as well as an efficient way to bind pathogens
and their components [10]. Apart from dyslipidemia, other
metabolic diseases such as obesity, diabetes, non-alcoholic
fatty liver disease, and atherosclerosis are tightly connected
to an altered immune response as reviewed here [11,12].
Patients suffering from lysosomal lipid storage disorders
that lead to an aberrant cellular lipid composition also
have been reported to show impaired immune responses
(Table 1) [13]. Chediak–Higashi syndrome patients, forwww.sciencedirect.com
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Membrane interactions of TLRs and associated proteins. TLR1/2/6 (green), TLR4 (blue), CD14 (red) embedded in the membrane. Bacterial
lipopeptides and LPS-MD2 complexes represented as circles. Different membrane lipid molecules (sphingolipids, cholesterol,
glycerophospholipids, glycolipids) are colored as in legend. The ordered (orange) and less-ordered (violet) membrane regions are shown. Different
posttranslational lipid modifications are represented as red fatty acid chains. Charges (+, ) depict the amino acid-lipid interactions. TLR adaptor
proteins are represented in blue. TLR (Toll-like receptor), TIR (Toll/IL-1 receptor domain), TMD (Transmembrane domain), TIRAP (TIR-domain
containing adaptor protein), TRAM (TRIF-related adaptor molecule), PIP2 (phosphatidylinositol bisphosphate-binding domain), G (glycine), C
(cysteine).instance, are known to suffer from severe immunodefi-
ciency and to be abnormally susceptible to pyogenic
infections [14]. Fabry and Gaucher disease patients have
elevated serum levels of different cytokines, and a mouse
model of Gaucher disease was used to demonstrate that
mutations in the Gba gene, encoding the enzyme gluco-
sylceramidase, contribute to neuroinflammation in these
mice (Table 1) [15–17]. Additional inflammatory pheno-
types observed in lysosomal storage disorders are
reviewed by Castaneda et al. [18]. Taken together, thesewww.sciencedirect.com observations in different pathological conditions high-
light the fact that altered lipid metabolism is connected
to severe changes of the cellular immune response.
TLR signaling components at cellular
membranes
As key players of the acute response to infection, TLRs
have been extensively studied. While the structure and
role of their extracellular ectodomain and intracellular
TIR domain are well described, the importance of theirCurrent Opinion in Cell Biology 2016, 39:28–36
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Table 1
Altered cytokine release in lysosomal lipid storage disorders in mouse and human
Disease Mutated
gene
Encoded protein Protein function Model/Tissue Result Publication
Fabry Gla Alpha-galactosidase A Hydrolysis of
globotriaosylceramides
Patient serum Low TNF, high IL-10, IL-1b,
transcript level, unstimulated
Safyan et al. [15]
Peripheral blood
mononuclear cells
High TNF, IL-6, IL-1b in DCs
and monocytes after LPS
stimulation
De Francesco et al. [77]
Gaucher Gba Glucosylceramidase Hydrolysis of
glucosylceramides
Gaucher mouse model,
cerebral tissue
High TNF, IL-1b, TGF,
MCSF, CCL2, CCL3, CCL5
transcript levels
Vitner et al. [16]
Patient serum High IL-6 and IL-10 Allen et al. [17]
Mesenchymal stromal cells High IL-8 and CCL2
transcript levels
Campeau et al. [78]
Patient-derived fibroblasts High IL-6 and IL-8 after TLR
stimulation
Ko¨berlin, Snijder et al. [13]
and unpublished results
Krabbe Galc Galactocerebrosidase Hydrolysis of
galactosylceramides
Twitcher mouse model, brain
tissue
High TNF and IL-6 detected
by immunohisto-chemistry
LeVine et al. [79]
Patient brain sections High iNOS, detected by
immunohistochemistry
Giri et al. [80]
Patient-derived fibroblasts High IL-6 after TLR
stimulation
Ko¨berlin, Snijder et al. [13]
Niemann-Pick A/B Smpd1 Sphingomyelin
phosphodiesterase
Hydrolysis of
sphingomyelin
Patient-derived fibroblasts Low IL-6 after TNF
stimulation
Perry et al. [81]
Niemann-Pick C Npc1 Niemann-Pick C1 protein Intracellular cholesterol
transport
Cerebrospinal fluid of
patients
High IL-3, CXCL5, IL-16,
CCL3, low IL-4, IL-10, IL-13,
IL-12p40 transcript levels
Cologna et al. [82]
Farber Asah1 Acid ceramidase Hydrolysis of ceramide Patient-derived fibroblasts Low IL-6 after stimulation Ko¨berlin, Snijder et al. [13]
Chediak–Higashi
syndrome
Lyst Lysosomal-trafficking
regulator
Vesicle formation,
endosomal protein
transport
Patient-derived fibroblasts Low IL-6, IL-1b, CXCL3,
CCL7, IL-1b after LPS
stimulation
Wang et al. [83]
Patient-derived natural killer
cells
High IFNg and TNF after
stimulation
Gil-Krzewska et al. [84]
Patient-derived fibroblasts Low IL-6 after stimulation Ko¨berlin, Snijder et al. [13]
Batten Cln3 Battenin Transport of endosomes,
lysosomes
Microglia from mouse model High IL-9, TNF, IL-1a/b Xiong et al. [85]
Sandhoff Hexb Beta-hexosaminidase
subunit beta
Beta subunit of
hexosaminidase;
hydrolysis of GM2
gangliosides
Whole brain tissue from
mouse model
High TNF, IL-1b Jeyakumar et al. [86]
Brain stem, cerebral cortex,
cerebellum from mouse
model
High MIP-1a Tsuji et al. [87]
Tay-Sachs Hexa Beta-hexosaminidase
subunit alpha
Alpha subunit of
hexosaminidase;
degradation of GM2
gangliosides
Cerebrospinal fluid from
patient
High TNF and IL-5 Hayase et al. [88]
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with the local lipid environment is less well understood
(Figure 1). The TMDs and juxtamembrane regions of
TLRs have been shown to be important in the formation
of homodimeric or heterodimeric receptor complexes as
well as to mediate the interaction with chaperones, such
as Unc93B1, involved in receptor sorting [19–21]. Other
co-factors that serve TLR sorting include TMED7, gp96,
and PRAT4A [22–24]. The cytosolic juxtamembrane
regions of TLRs tend to be basic in character and,
according to observations from other transmembrane
proteins, might be involved in the interaction with anion-
ic glycerophospholipids such as phosphatidylserines (PS)
and phosphatidylinositols (PI) found on the inner leaflet
of the membrane [1,25]. Several TLRs also contain
cysteine residues in the cytosolic juxtamembrane region
that, at least for TLR2, were reported to be palmitoylated
and functionally important for signaling (Figure 1)
[26,27]. These posttranslational lipid modifications are
known to regulate dynamic associations of transmem-
brane proteins with membrane microdomains, also known
as lipid rafts [28], and might be involved in TLR re-
localization within the membrane. Further, most TLRs
have been shown to require TIR domain-containing,
membrane-interacting bridging factors for functional sig-
naling [29]. TIRAP/MAL, for example, is required for
signaling by TLR2 and TLR4 from the cell surface and is
also required for the response of several endosomal TLRs
induced by their natural ligands [30,31,32]. In addition
to a C-terminal TIR domain, TIRAP/MAL harbors a
basic N-terminal lipid-binding domain that mediates
peripheral interactions with anionic glycerophospholipids
found on the inner leaflet of the membrane (Figure 1)
[30,33]. A second bridging factor, TRAM/TICAM2 was
shown to be important for TLR4 signaling from endoso-
mal compartments [34,35]. This protein contains an N-
terminal myristoylation on a glycine residue followed by
several basic amino acids involved in protein–lipid inter-
actions at the membrane [34,36]. Ligand-induced endo-
cytosis has been best-described for TLR4 and proceeds
via internalization into clathrin-coated and RAB11A-as-
sociated vesicles in a dynamin-dependent fashion. Inter-
estingly, this process seems to be dependent on the GPI-
anchored co-factor CD14 and involves the tyrosine kinase
SYK and the phospholipase PLCg2 [37,38]. Overall, these
specific lipid associations of TLR co-factors as well as the
fact that TLRs themselves are transmembrane proteins
suggest a strong dependence of TLR signaling on the
local membrane environment.
Membrane microdomains in TLR signaling
and endocytosis
Several TLRs, including TLR2, 4, and 9, are dynamically
recruited into lipid rafts upon activation [39–41]. These
structures are thought to be locally enriched in cholesterol
and sphingolipids, serving as activation platforms forwww.sciencedirect.com many signaling processes, including TLR-proximal sig-
naling events [42].
As a highly abundant membrane lipid, cholesterol plays
an important role in TLR biology: Evidence from murine
models studying deficiencies in the cholesterol efflux
transporters ABCA1 and ABCG1 suggests that accumu-
lation of free cholesterol renders macrophages hyperre-
sponsive to several TLR ligands, presumably as a
consequence of altered plasma membrane lipid composi-
tion [41,43–45]. Indeed, TLR4 and 9 showed increased
receptor recruitment into lipid rafts in ABCA1-deficient
macrophages [41]. Conversely, LXR-dependent upregu-
lation of ABCA1 in macrophages led to a change in
cellular lipid organization and inhibition of TLR-depen-
dent signaling processes [46]. Similarly, depletion using
cholesterol-reducing cyclodextrins, nystatin, or treatment
with the HMG-CoA reductase inhibitor atorvastatin at-
tenuated TLR-dependent signaling processes, highlight-
ing the importance of cholesterol in TLR signaling
[41,43,44,47]. Similar to the impact of ABCA1-deficiency
on macrophages, the raft-associated, lipid-modifying en-
zyme sphingomyelin phosphodiesterase acid-like 3B
(SMPDL3B) was identified as a negative regulator of
TLR signaling. Knockdown or knockout of this phospho-
diesterase in macrophages led to altered cellular lipid
composition and membrane fluidity, associated with an
increased responsiveness to TLR ligands [48].
Interestingly, other mouse models deficient for genes
located in the sphingolipid metabolic network were
reported to show altered immune receptor surface levels.
Macrophages from Sgms1-deficient mice (sphingomyelin
synthase 1) or Sgms2-deficient mice, for example, showed
reduced TLR4 expression at the cell surface compared to
control macrophages, indicative of impaired receptor
trafficking or recycling [49,50]. Additionally, macro-
phages from haploinsufficient Sptlc2 (serine palmitoyl
transferase 2) mice also showed impaired LPS-induced
downstream signaling due to attenuated TLR4 recruit-
ment to the membrane [51]. Ali et al. could further show
that Cers2 (ceramide synthase 2) null mice were protected
from LPS-induced liver failure as TNF receptor inter-
nalization was impaired in their hepatocytes [52]. One
mechanistic explanation for defective receptor endocyto-
sis in an altered lipid environment could be a switch from
clathrin-mediated to lipid raft-mediated endocytosis, as
has been observed for the activation of AC6 (adenylyl
cyclase 6) in macrophages. In LPS-stimulated RAW264.7
cells or BMDMs (bone marrow-derived macrophages) the
activation of AC6 by forskolin could rescue the blockade
of TLR4 endocytosis upon dynamin inhibition. Hence,
the authors suggest that AC6 acts as a negative regulator
of TLR4 signaling by shifting its endocytosis to a lipid
raft-mediated process, thereby dampening downstream
signaling [53]. These various observations connecting
TLR signaling and altered lipid composition as well asCurrent Opinion in Cell Biology 2016, 39:28–36
32 Cell regulationthe dependence of the TLRs, their co-factors, and the
related processes such as endocytosis on membrane lipids
show a strong link between global membrane lipid com-
position and TLR signaling.
Specific protein–lipid interactions
While the role of lipid rafts as structural organizers of
TLR biology seems well established, the contribution of
individual lipid species surrounding or binding to TLRs
and associated proteins is less clear. The so-called annular
lipids compose a lipid shell around the transmembrane
domains of proteins and move together in the membrane
as protein–lipid complexes [54]. While these lipids still
show dynamic exchange with the surrounding environ-
ment, non-annular or structural lipids bind to proteins
more tightly and may serve a more specific function
[54,55].
Lipids can affect associated membrane proteins in nu-
merous ways, including parameters such as stability,
activity, topology, and oligomerization state [54,55]. As
there are currently no reports on how TLRs can interact
with specific membrane lipid species on the molecular
level, we present some examples of state-of-the-art tech-
nologies that have been successfully employed to reveal
such protein–lipid interactions [56]. Electron crystallog-
raphy was used to determine the atomic structure of a
mammalian aquaporin in complex with an annular shell of
28 synthetic phospholipid molecules (DMPC) revealing
multiple hydrophobic and electrostatic protein–lipid
interactions [57]. Similarly, X-ray crystallography was
successfully used to determine the structures of multiple
membrane proteins in complex with specific lipids, re-
vealing different modes for protein–lipid interactions
involving only parts or the entire lipid molecule [55].
Cholesterol molecules, for example, were found as inte-
gral, structural components of G protein-coupled recep-
tors such as the human b2-adrenergic receptor, important
for protein stability [58,59].
On the basis of sequence analysis, it has been proposed,
that several TLRs harbor putative cholesterol-binding
motifs (CRAC and CARC) in their cytosolic juxtamem-
brane domains, potentially important for protein–lipid
interactions [21,60]. Experimental evidence for this, how-
ever, is currently pending. Photoreactive sterol probes
combined with proteomics could provide an interesting
tool to study such associations in detail [61]. Apart from
cholesterol, certain phospholipids have been found to
specifically interact with transmembrane proteins to reg-
ulate their function [54,55]. Contreras et al. could show
the specific binding of sphingomyelin SM C18 to the
TMD of p24, which regulates the sorting of proteins via
the COPI pathway [62]. Interestingly, this binding
depends both on the head group and on the length of
the fatty acid chains and led to the identification of a
binding motif for SM C18 in the transmembrane domainCurrent Opinion in Cell Biology 2016, 39:28–36 of the protein. Sequence comparison of different TLRs
revealed that this motif is also present in the TMDs of
TLR3 and TLR5 indicating that they may specifically
bind to SM C18 in the membrane [60]. The absence of
this motif in other TLR sequences, however, does not
mean that these TLRs do not bind specifically to other
lipids. In fact, on the basis of the approach used by
Contreras et al., it is to be expected that several additional
lipid-binding motifs will be uncovered in the near future.
One example for an individual lipid affecting TLR sig-
naling is a naturally occurring phosphatidylserine species
(SAPS or PS C38:4) which reduced the LPS-induced
release of CXCL8 and CXCL10 in THP-1 cells, while
IL-1b-induced cytokine release was not affected [63].
This PS species also inhibited the response to TLR2 and
TLR7 stimulation as well as the association of TLR4 with
its co-factor CD14 or the lipid raft marker GM1, as shown
by fluorescence resonance energy transfer. This finding
suggests a specific role for PS C38:4 in TLR responses
and not in IL-1b receptor responses. Additionally, in a
more recent study, PS C38:4 negatively correlated with
TLR-induced IL-6 release across a panel of different cell
lines, highlighting its role as a negative regulator of TLR-
mediated cytokine release [13].
Even though there is no direct experimental evidence, it
is highly likely that TLRs are at least in part modulated
via specific protein–lipid interactions. With the advance-
ment of structural biology and approaches combining
proteomics and lipidomics, this will be an interesting
domain of future research [64].
Membrane lipids and cytokine secretion
Lipids also play important roles in other membrane-
dependent processes involved in the TLR response, such
as cytokine secretion. The PC (phosphatidylcholine)
biosynthetic pathway, for instance, was reported to be
important for cytokine secretion. Mice deficient for Ccta,
the gene that is associated with the first step of PC
synthesis, displayed an intracellular accumulation of
TNF and IL-6, and impaired secretion in response to
LPS stimulation [65]. In line with this report, several
different PC species were suggested to be beneficial or
even necessary in the process of TLR-induced cytokine
secretion [13]. Additionally, Cers2 knockdown cells also
accumulated intracellular IL-6, pointing towards the in-
volvement of other lipid classes such as ceramides in
TLR-induced cytokine secretion [13]. A potential
mechanism of these observed secretory blocks could
involve the p110d PI3K isoform, which is induced by
LPS or IFNg in macrophages, and is important for
membrane fission at the Golgi, as loss-of-function cell
lines and genetic inactivation in mice showed accumulat-
ing TNF after stimulation [66]. Polyunsaturated phos-
pholipid species have also been reported to be importantwww.sciencedirect.com
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[67].
Systematic and global approaches to study
lipid function
Apart from the targeted approaches described previously,
systematic studies conducted in the past years have
contributed largely to the advances in dissecting the lipid
composition of cells and their function. Especially the
development of quantitative lipidomics has empowered
these studies to identify the lipidome of cells, that is, the
variety and great number of different lipid species a cell is
comprised of [4,68,69]. Using systematic approaches to
study different processes in lipid metabolism, novel met-
abolic connections as well as new lipid transfer and
binding mechanisms could be revealed [70,71,72].
In an orthogonal approach dissecting early and late stages
of TLR signaling in RAW264.7 macrophages, the combi-
nation of genetic perturbations with quantitative lipido-
mics and a detailed functional characterization of TLR-
dependent signaling steps allowed the identification of
individual membrane lipid species enhancing or damp-
ening the inflammatory response [13]. Specifically, the
quantification of 245 different lipid species could be used
to functionally annotate these lipids in TLR-mediated
responses, providing for the first time a map of lipid
function. Interestingly, this map also indicated the im-
portance of distinguishing between the saturation level or
chain length of different sphingolipid and glyceropho-
spholipid species, as their functional roles were shown to
be quite diverse. Several long-chained ceramides, for
instance, were found to dampen LPS-induced IL-6 re-
lease, while some short-chained hydroxylated or dihydro-
ceramides were shown to enhance cytokine release.
Importantly, this approach described the function of
individual lipids within the complexity of membranes,
and not in isolation across a group of different genetic
perturbations. It further uncovered a model, which could
be used to predict the inflammatory state of a cell based
only on its changes in lipid composition. This model was
successfully applied in a study describing the lipid-modi-
fying enzyme SMPDL3B as negative regulator of TLR
responses and revealed some long-chained ceramide spe-
cies as potential mediators of the inflammatory phenotype
observed [48]. Further, the TLR response of primary
human fibroblasts derived from patients suffering from
lipid storage disorders could also be accurately predicted
only based on changes in their lipid composition (Table 1)
[13]. This framework and the predictive model are
likely to be applicable to various biological processes,
enabling the systematic annotation of membrane lipid
function in the future.
Outlook and future directions
Here, we have discussed current knowledge on lipid
biology in the context of TLR signaling, illustratingwww.sciencedirect.com the complexity of the different processes, and how di-
verse approaches are advancing this field. One important
aspect for future studies will be to identify the local
contribution of individual lipid species compared to the
global role of membrane lipid composition. Major cellular
processes, including cell division, migration, apoptosis,
and autophagy are currently under investigation and have
already revealed novel and exciting connections between
lipid metabolism and cell biology [73,74–76]. Given the
high order of complexity of thousands of different lipid
species functioning and interacting in various processes
within the cell, the integration of transcriptional, proteo-
mic, lipidomic, and other metabolomic data will be a
promising avenue for the understanding of these funda-
mental relationships in the future.
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